Leslie joined Lyfebulb in December, 2017 as its Chief Investment Officer. She is responsible for all financial matters and will also contribute to the overall strategy and communications in the Company. Her principle goal will be to build a portfolio of investments for Lyfebulb, with the prime investment candidates coming from the Innovation Summits the Company hosts with its strategic partners. Prior to Lyfebulb, Leslie worked in private equity for a family office investment partnership. She helped build an anatomic and molecular diagnostics platform through a series of acquisitions. Previously, she led Corporate Communications and contributed to M&A and financial affairs at AdvancePCS (now part of CVS Corporation), one of the largest PBMs in the US. Leslie began her career in Investment Banking at JP Morgan in the Consumer industry sector and then spent five years in Corporate and Investment Banking at Montgomery Securities (now Bank of America) in the Healthcare Services group. Leslie graduated with distinction from the Wharton School at the University of Pennsylvania for her MBA and earned her BS in Commerce from the McIntire School of Commerce at the University of Virginia.